DENALI THERAPEUTICS
Denali Therapeutics is a biotechnology company focused on the discovery and development of therapies for patients with neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, ALS and others. Denali was founded by scientists, industry experts and investors who share the vision that recent scientific insights into the genetic causes and biological processes underlying neurodegenerative disease, together with new translational medicine tools, offer an unprecedented opportunity to discover and develop effective medicines. Denali is rigorously pursuing a science-driven approach to translational medicine and clinical development.
DENALI THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Health Diagnostics Therapeutics
Founded:
2013-10-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.denalitherapeutics.com
Total Employee:
251+
Status:
Active
Total Funding:
347 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Domain Not Resolving IPv6 Google Maps Amazon Route 53 Amazon S3 Typekit Amazon SSL
Similar Organizations
Cofactor Genomics
Cofactor Genomics builds multidimensional models of disease to deliver true precision medicine.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Baillie Gifford
Baillie Gifford investment in Series B - Denali Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Denali Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Denali Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Denali Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series B - Denali Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Venture Round - Denali Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series A - Denali Therapeutics
Biomatics Capital Partners
Biomatics Capital Partners investment in Series A - Denali Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Denali Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series A - Denali Therapeutics
Key Employee Changes
Official Site Inspections
http://www.denalitherapeutics.com Semrush global rank: 2.53 M Semrush visits lastest month: 6.94 K
- Host name: ec2-52-37-201-116.us-west-2.compute.amazonaws.com
- IP address: 52.37.201.116
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Denali Therapeutics"
Leadership - Denali
We have assembled a team with deep scientific, clinical, business and leadership experience …See details»
Denali | Patient Community Engagement - Engage Parkinsons
We listen to those impacted by neurodegenerative and lysosomal storage diseases and seek …See details»
Denali Therapeutics - LinkedIn
Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and ...See details»
Denali Therapeutics - Crunchbase Company Profile
Denali Therapeutics reported its fourth quarter and full year 2023 financial results, indicating a loss per share of US$0.68 in the first quarter of 2024, compared to …See details»
Corporate Overview - Denali Therapeutics
Corporate Overview - Denali TherapeuticsSee details»
Denali Therapeutics Announces Key Anticipated 2023 Milestones …
Jan 9, 2023 SOUTH SAN FRANCISCO, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Denali …See details»
Denali Therapeutics Inc: Overview - GlobalData
Website www.denalitherapeutics.com Telephone 1 650 8668548. No of Employees 395. …See details»
Denali Therapeutics Announces Key Anticipated 2024 Milestones …
Jan 8, 2024 Complete enrollment in Denali-led, late-stage programs for MPS II and ALS, and …See details»
Denali | Defeat Degeneration
©2020 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080See details»
Denali Therapeutics - Craft
Oct 28, 2024 Denali Therapeutics has 5 employees across 3 locations and $330.53 m in …See details»
Denali: Pioneering Neurodegenerative Space With Blood-Brain …
Apr 17, 2023 denalitherapeutics.com The findings are especially significant given the …See details»
Working At Denali Therapeutics: Company Overview and Culture
Mar 14, 2024 www.denalitherapeutics.com. Organization Type. Public. Social Media. Denali …See details»
Partnering - Denali
©2020 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080See details»
Denali Therapeutics Announces New Data and Expansion of Its …
Feb 7, 2024 Denali Therapeutics Inc. New data show additional improvement and …See details»
Denali Therapeutics Announces Positive Clinical Results and
Oct 6, 2021 Investor Relations Contact: Media Contacts: Laura Hansen, Ph.D. Vice …See details»
Pipeline - Denali
©2020 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080See details»
Denali Therapeutics Inc. (DNLI) - Stock Analysis
4 days ago Website https://www.denalitherapeutics.com. Full Company Profile. Financial …See details»
Denali | STEM Outreach Overview
Denali’s STEM Outreach Program works with local and national partners to encourage more …See details»